Research Article

Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma

Figure 4

ROC curves showing the prognostic utility of the 3-DNA methylation biomarker. (a) The ROC curve of the 3-DNA methylation biomarker in predicting the OS of STS patients in the training dataset. The AUC is 0.844 (, 95% CI: 0.740–0.948). (b) The ROC curve of the 3-DNA methylation biomarker prognostic predictor in the testing dataset. The AUC is 0.710 (, 95% CI: 0.595–0.823).
(a)
(b)